Original news and analysis on international IP policy
The adoption of a Development Agenda by the General Assembly of the World Intellectual Property Organization three years ago was seen by most as a success for developing countries and a sign that the organisation was assuming its role as a United Nations agency to a fuller extent. However, according to a lead official on Development Agenda implementation, there is still a long way to go and changes are needed.
Although indigenous peoples’ rights are recognised in a number of international declarations, the implementation of those rights is difficult to achieve, according to panellists at an event opening this week’s World Intellectual Property Organization negotiations toward a treaty to protect traditional knowledge, folklore and genetic resources.
Developing countries are not taking advantage of discoveries made by their scientists and researchers because they lack an appropriate intellectual property infrastructure and expertise, according to a long-time United States proponent of IP rights speaking in Geneva last week. He called for development funds to be redirected to address these shortcomings rather than only supporting IP enforcement initiatives.
The World Intellectual Property Organization committee in charge of overseeing the implementation of the organisation’s cornerstone Development Agenda, ended abruptly when the session was suspended after a strong disagreement over a development project.
Building on recent momentum that has produced negotiating texts towards an international instrument to protect folklore, traditional knowledge and genetic resources, delegates to the World Intellectual Property Organization next week will try to clean the texts that still bear signs of division.
A debate has arisen this week among World Intellectual Property Organization members over a WIPO secretariat report on implementation of the 2007 Development Agenda, which was intended to infuse a stronger development dimension into the UN agency’s activities.
The World Intellectual Property Organization Internal Audit and Oversight Division is seeking expressions of interest from consultants to conduct an evaluation and analysis of Kenya’s performance with intellectual property rights during the years 2005 to 2010. The study aims to help WIPO members to assess the effect of the UN agency’s work in the country during that time, and to boost learning and accountability.
Intellectual property has often been considered by developing countries as a hindrance to development rather than a driving force. Next week, delegates to the World Intellectual Property Organization will discuss the implementation of the organisation’s commitment to take development considerations more substantially into its work. In particular, delegates are expected to try to agree on the coordination mechanism of the committee responsible for the effort.
The United States mission in Geneva announced today a new international initiative to raise public awareness about protection of intellectual property rights. The initiative is a cooperation with the World Intellectual Property Organization and has support from the governments of Kenya, Morocco and the Philippines, US Ambassador Betty King said at a reception.
More than two years after construction was begun and 13 years since its approval, a large new World Intellectual Property Organization office building quietly opened doors in March and the exodus from across the street and several other locations in Geneva began for some 500 employees of the United Nations organisation.
In its slick new office building in Geneva, the World Intellectual Property Organization this week celebrated the 2 millionth patent filing under the Patent Cooperation Treaty, which it manages. In the foyer with white clad windows, a crowd was assembled to hear the praise of the international patent filing system.
The Medicines Patent Pool, an initiative aiming at increasing access to HIV drugs through voluntary licences of patented drugs, has launched a new database of patent information on HIV medicines.